Univar (UNVR) Closes Sale of Environmental Sciences BusinessHomeMailNewsFinanceSportsEntertainmentSearchMobileMoreYahooSearchNo matching results for ''Tip: Try a valid symbol or a specific company name for relevant resultsSign inMailFinance HomeWatchlistsMy PortfolioScreenersPremiumMarketsIndustriesPersonal FinanceVideosNewsTechU.S. Markets closedS&P 5002,978.76-137.63(-4.42%)Dow 3025,766.64-1,190.95(-4.42%)Nasdaq8,566.48-414.29(-4.61%)Univar (UNVR) Closes Sale of Environmental Sciences BusinessZacks Equity ResearchZacksJanuary 7, 2020ReblogShareTweetShareUnivar Solutions Inc. UNVR has completed the sale of its Environmental Sciences business to affiliates of AEA Investors LP for $195 million. The company announced the deal in December 2019.Univar will use the net proceeds from the deal to pay down existing debt, per its previously stated plan.With the completion of the transaction, Univar will now focus more on its core chemical and ingredient distribution businesses.Notably, the company, in December 2019, noted that the divestiture will be a 'win-win' for Environmental Sciences’ dedicated employees, supplier partners and loyal customers. Also, the transaction’s total economic benefit is expected to be enhanced by cost avoidance opportunities.The Environmental Sciences business is a leading pest management business based in Austin, TX. The business serves the expanding pest control market with unmatched products and services as well as educational and technology resources.In connection with the deal, Piper Jaffray & Co. and Stinson LLP acted as the financial advisor and legal counselor, respectively, for Univar.Univar’s shares have gained 22% over a year against a 22.3% decline recorded by its industry. View photos In November 2019, the company revised the adjusted EBITDA forecast for 2019, factoring in the lower-than-expected demand for chemicals and ingredients. Further, Univar expects adjusted EBITDA of $700-$725 million for the year compared with $725-$740 million mentioned earlier.Moreover, the company expects adjusted EBITDA of $155-$180 million for the fourth quarter of 2019, suggesting rise from $144 million reported in the year-ago quarter.Univar Inc. Price and Consensus View photosUnivar Inc. Price and ConsensusMoreUnivar Inc. price-consensus-chart | Univar Inc. QuoteZacks Rank & Stocks to ConsiderUnivar currently carries a Zacks Rank #3 (Hold).Some better-ranked stocks in the basic materials space are Daqo New Energy Corp. DQ, Pan American Silver Corp. PAAS and Sibanye Gold Limited SBGL.Daqo New Energy has projected earnings growth rate of 294.7% for 2020. The company’s shares have rallied 106.7% in a year. It sports a Zacks Rank #1 (Strong Buy) at present. You can see the complete list of today’s Zacks #1 Rank stocks here.Pan American Silver has an estimated earnings growth rate of 38.1% for 2020. It currently flaunts a Zacks Rank #1. The company’s shares have gained 53.1% in a year.Sibanye Gold has a projected earnings growth rate of 587.5% for 2020 and a Zacks Rank #2 (Buy) at present. The company’s shares have soared 242.9% in a year.Just Released: Zacks’ 7 Best Stocks for TodayExperts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.6% per year.These 7 were selected because of their superior potential for immediate breakout.See these time-sensitive tickers now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Univar Inc. (UNVR) : Free Stock Analysis Report DAQO New Energy Corp. (DQ) : Free Stock Analysis Report Sibanye Gold Limited (SBGL) : Free Stock Analysis Report Pan American Silver Corp. (PAAS) : Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment ResearchReblogShareTweetShareRecently ViewedYour list is empty.What to Read NextUnivar (UNVR) Earnings and Revenues Lag Estimates in Q4ZacksBiocontainment expert on coronavirus: There's no need for average people to panic yetYahoo FinanceA drug shortage due to the coronavirus is a 'considerable risk:' Fmr. FDA deputy commissionerYahoo Finance VideoStock market live updates: Dow drops 1190 points amid coronavirus fears, S&P 500 sees fastest correction in historyYahoo FinanceAmid coronavirus, bitcoin has fallen 6% this week to below $8,800Yahoo FinanceEl-Erian: The Fed will cut rates in March, if not beforeYahoo Finance VideoDelfi Limited Beat Analyst Estimates: See What The Consensus Is Forecasting For Next YearSimply Wall St.'Stuck in no man’s land': A working mom details dealing with her sick child's student loan billYahoo FinanceMost face masks won’t protect you from the coronavirusYahoo FinanceRichard Branson’s Wealth Falls to Earth as Virgin Galactic SputtersBloombergCoronavirus-induced stock selloff means IPO market is 'on holiday': veteran IPO analystYahoo FinanceMarket Watcher: Over six months we will see the markets higher Yahoo Finance VideoDoes CSE Global Limited's (SGX:544) Past Performance Indicate A Stronger Future?Simply Wall St.Don’t buy the stock dip yet, says Goldman as it warns coronavirus will wipe out earnings growth this yearMarketWatchStock market live updates: Stock futures climb after historic rout; coronavirus fears persistYahoo FinanceQ4 e-commerce sales are what's 'saving Walmart': AnalystYahoo Finance Video